Q
QuantAbundanciaAbundance, Quantified.

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

24,834 signal articles · 250 in last 24h · 118,371 total before filter · latest 35m ago
250last 24h
1547last 7d
248● bullish (7d)
162● bearish (7d)
205publishers
AllMacro301Earnings626M&A97Regulatory26Product14Analyst23
✕ clear all filtersticker: NVDASentiment:bullishneutralbearish✓ showing all (incl. clickbait)
Fundstrat’s Tom Lee: AI Is a Once in a Lifetime Story – Why Easing Inflation in H2 2026 Could Fuel the Next Rally
24/7 Wall St.40d agobullish
Fundstrat’s Tom Lee: AI Is a Once in a Lifetime Story – Why Easing Inflation in H2 2026 Could Fuel the Next Rally

Fundstrat’s Tom Lee returned to CNBC’s Morning Call Sheet on Thursday, July 9, alongside JonesTrading’s Mike O’Rourke and Vital Knowledge’s Adam Crisafulli, to discuss a market that is simultaneously celebrating the AI build-out while rotating into value and defensive names. Lee argued: “AI is probably one of the most important structural stories in our lifetime.” ... Fundstrat’s Tom Lee: AI Is a Once in a Lifetime Story – Why Easing Inflation in H2 2026 Could Fuel the Next Rally

AMD’s $300 Billion Ambition Is Putting Pressure on Rivals
24/7 Wall St.40d agoneutral
AMD’s $300 Billion Ambition Is Putting Pressure on Rivals

Six gigawatts. That is the total AMD Instinct GPU capacity AMD (NASDAQ:AMD) will deploy for Meta under a partnership disclosed alongside its most recent earnings, with the first 1-gigawatt tranche powered by a custom MI450-based GPU. For scale reference, one gigawatt is roughly the output of a large nuclear reactor. Meta is committing to power-plant-scale ... AMD’s $300 Billion Ambition Is Putting Pressure on Rivals

SpaceX Added to Nasdaq-100 and Could Trigger $4.3B in Forced Passive Buying
24/7 Wall St.40d agobullish
SpaceX Added to Nasdaq-100 and Could Trigger $4.3B in Forced Passive Buying

CNBC’s Leslie Picker walked Squawk Box viewers through one of the most mechanically consequential trading events of 2026: the rebalance that will force index funds to absorb billions in SpaceX (NASDAQ: SPCX) stock, whether their managers like the valuation or not. Picker’s framing was blunt: “Index funds tracking the Nasdaq-100 will have to start buying ... SpaceX Added to Nasdaq-100 and Could Trigger $4.3B in Forced Passive Buying

MARA Is Up 19% Today: Is It Outperforming Other Crypto Stocks Like Riot and CleanSpark?
24/7 Wall St.40d agobullish
MARA Is Up 19% Today: Is It Outperforming Other Crypto Stocks Like Riot and CleanSpark?

Shares of Marathon Digital (NASDAQ:MARA) are up 18% in midday trading Thursday, changing hands at $14.27. The move puts Marathon Digital stock at the top of the crypto miner leaderboard on July 9, 2026, ahead of peers Riot Platforms (NASDAQ:RIOT), CleanSpark (NASDAQ:CLSK), and TeraWulf (NASDAQ:WULF), all of which are also higher. The rally caps a ... MARA Is Up 19% Today: Is It Outperforming Other Crypto Stocks Like Riot and CleanSpark?

Prediction: Bitcoin’s Next Move Could Make or Break MicroStrategy Stock
24/7 Wall St.40d agoneutral
Prediction: Bitcoin’s Next Move Could Make or Break MicroStrategy Stock

MicroStrategy (NASDAQ:MSTR) has become the market’s cleanest proxy for Bitcoin, and right now that is a double-edged sword. With BTC down 27.34% year to date and MSTR down 35.93% YTD, sentiment has cratered even as the company kept stacking coins. My model still sees meaningful upside from here, but the setup is delicate. Our 24/7 ... Prediction: Bitcoin’s Next Move Could Make or Break MicroStrategy Stock

AMD Jumps 7%, Intel Climbs 5%, Broadcom Rises 2% as Tom Lee Calls the Chip Selloff a Buying Opportunity
24/7 Wall St.40d agobullish
AMD Jumps 7%, Intel Climbs 5%, Broadcom Rises 2% as Tom Lee Calls the Chip Selloff a Buying Opportunity

Shares of Advanced Micro Devices (NASDAQ:AMD) are up 7% to $555.26 in early trading Thursday, leading a broad semiconductor rebound. Intel (NASDAQ:INTC) shares are up 5% to $116.14, and Broadcom (NASDAQ:AVGO) shares are up 2% to $396. The bounce reverses a rough stretch for chip names after several sessions of selling. The iShares Semiconductor ETF ... AMD Jumps 7%, Intel Climbs 5%, Broadcom Rises 2% as Tom Lee Calls the Chip Selloff a Buying Opportunity

PepsiCo Price Prediction: Is The Stock a Buy Before Earnings?
24/7 Wall St.40d agobullish
PepsiCo Price Prediction: Is The Stock a Buy Before Earnings?

With PepsiCo (NASDAQ:PEP) set to report Q2 2026 earnings before the market opens on July 9, 2026, investors are asking whether to buy the beverage and snacks giant ahead of the earnings report. Our 24/7 Wall St. price target for PepsiCo is $171.20, implying 18.09% upside from $144.98. Our recommendation is a buy, with a ... PepsiCo Price Prediction: Is The Stock a Buy Before Earnings?

Why NVIDIA Might Be Immune to the Semiconductor Sell-Off
24/7 Wall St.40d agobearish
Why NVIDIA Might Be Immune to the Semiconductor Sell-Off

It’s been an unforgiving past week for the iShares Semiconductor ETF (NASDAQ:SOXX), down just over 8%, even with the 3.6% bounce on Wednesday. Meanwhile, shares of Nvidia (NASDAQ:NVDA) are up close to 6%, a stark contrast to the action we’ve seen in the semis of late. In many ways, it feels like Nvidia trades more ... Why NVIDIA Might Be Immune to the Semiconductor Sell-Off

3 Cloud Computing Stocks to Buy Before Earnings Season in July
24/7 Wall St.40d agobullish
3 Cloud Computing Stocks to Buy Before Earnings Season in July

July is shaping up to be the pivotal month for cloud computing investors in 2026. All three of the companies below report late-July results with their cloud franchises accelerating, not decelerating, into the print. Enterprise AI workloads are still running ahead of supply, hyperscaler backlogs are ballooning, and the market has already begun to sort ... 3 Cloud Computing Stocks to Buy Before Earnings Season in July

3 High Growth GLP-1 Biotech Winners to Buy in July
24/7 Wall St.40d agobullish
3 High Growth GLP-1 Biotech Winners to Buy in July

The GLP-1 trade has matured from a single-stock story into a tiered opportunity set. Demand for obesity therapeutics keeps expanding as lower-cost, easier-to-administer oral pill versions of the current injectable GLP-1s are introduced to the market in 2026, and the field now spans an entrenched leader, a deep-value incumbent, and a clinical-stage challenger with multiple ... 3 High Growth GLP-1 Biotech Winners to Buy in July